Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 220.77 --0 (-0%)
Previous Close $220.77    52 Week High $333.65 
Open $220.77    52 Week Low $223.02 
Day High $220.77    P/E 28.27 
Day Low $220.77    EPS $7.81 
Volume 474